Cornell researchers have developed a bioelectric device that can detect and classify new variants of coronavirus, and potentially other viruses, such as measles and influenza, to identify those that are most harmful.
Most pandemics in the past century were sparked by a pathogen jumping from animals to humans. This moment of zoonotic spillover is the focus of a multidisciplinary team of researchers led by Raina Plowright, the Rudolf J. and Katharine L. Steffen Professor in the Cornell College of Veterinary Medicine’s Department of Public and Ecosystem Health.
Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine.
The study found that key CD8+ T cells showed signs of constant stimulation that lead to an exhausted state, a condition that is well-studied in cancer.
A two-day training program for the New York State Department of Homeland Security and Emergency Services helps local health officials and first responders convey key messages in a crisis.
Researchers have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2 induces new cases of diabetes and worsens complications in people who already have it.
Cornell researchers have identified a shift that occurs in canine coronavirus that points to a possible pattern of change found in other coronaviruses and which may provide clues to how they transmit to humans from animals.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
Malnutrition of Indian children rose dramatically during the COVID-19 pandemic, according to new research from the Tata-Cornell Institute for Agriculture and Nutrition.
A study involving more than 3.6 million people who’d already received COVID vaccinations found that offering free Lyft rides to a vaccination site was no more enticing than simply reminding people of the importance of getting boosted.